# Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.

> **NCT06637189** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Ginefiv** · enrollment: 144 (estimated)

## Conditions studied

- Stimulation in the Ovary
- Embryo
- Oocyte
- Oocyte Retrieval
- Fertilization in Vitro
- Blastocyst
- PGT-A

## Interventions

- **DRUG:** Ganirelix
- **DRUG:** Medroxyprogesterone Acetate 10 MG

## Key facts

- **NCT ID:** NCT06637189
- **Lead sponsor:** Ginefiv
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-15
- **Primary completion:** 2025-06-15
- **Final completion:** 2025-12-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2024-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06637189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06637189, "Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06637189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*